Researchers have secured NIH funding for the development of a new neuroimaging system.
Neurological symptoms associated with COVID-19, from losing the sense of smell to stroke, are linked to a six-fold higher risk of dying as a result of coronavirus.
Study reports a metabolite produced following the consumption of dietary soy may lower risk factors for dementia.
Researchers have developed a new blood test that could help to identify infants who may be experiencing bleeding in the brain as a result of abusive head trauma.
According to researchers, those who live in colder regions with less daytime sun light drink more alcohol than those who live in warm areas. Climate, researchers say, may impact the prevalence of alcoholism and alcoholic cirrhosis.
A new COVID-19 vaccine produces antibodies specific to SARS-CoV-2 at quantities believed sufficient for neutralizing the virus, a mouse model study reveals. The new vaccine using an innovative microneedle array on fingertip-sized pads, which increases the vaccine potency.
Gene expression rhythms in the brains of those with schizophrenia are highly disrupted a new study reports. The expression of genes is significantly different in those with schizophrenia who died at night compared to the general population. The findings provide new insight into a potential mechanism that underlies gene expression in the dorsolateral prefrontal cortex in those with schizophrenia.
Anti-psychotic drugs do not only block dopamine signaling in the brain, they also block dopamine signaling in the pancreas. Blocking dopamine signaling in the pancreas leads to uncontrolled production of blood-glucose regulating hormones, increasing obesity and diabetes risks.